[HTML][HTML] Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options

CR Lee, JH Lee, M Park, KS Park, IK Bae… - Frontiers in cellular …, 2017 - frontiersin.org
Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible
for hospital-acquired nosocomial infections in the modern healthcare system. Due to the …

[HTML][HTML] Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside

MF Lin, CY Lan - World Journal of Clinical Cases: WJCC, 2014 - ncbi.nlm.nih.gov
Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …

Understanding the epidemiology of multi-drug resistant gram-negative bacilli in the Middle East using a one health approach

I Dandachi, A Chaddad, J Hanna, J Matta… - Frontiers in …, 2019 - frontiersin.org
In the last decade, extended-spectrum cephalosporin and carbapenem resistant Gram-
negative bacilli (GNB) have been extensively reported in the literature as being …

[HTML][HTML] Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings

MNL Kurihara, RO Sales, KE Silva… - Revista da Sociedade …, 2020 - SciELO Brasil
INTRODUCTION: The increase in the prevalence of multidrug-resistant Acinetobacter
baumannii infections in hospital settings has rapidly emerged worldwide as a serious health …

Contribution of PER-type and NDM-type β-lactamases to cefiderocol resistance in Acinetobacter baumannii

L Poirel, M Sadek, P Nordmann - Antimicrobial Agents and …, 2021 - Am Soc Microbiol
Cefiderocol (FDC) is a recently developed siderophore cephalosporin showing excellent
antibacterial activity against Gram-negative bacteria, including Acinetobacter baumannii. By …

Mobile genetic elements carrying aminoglycoside resistance genes in Acinetobacter baumannii isolates belonging to global clone 2

G Naderi, M Talebi, R Gheybizadeh, A Seifi… - Frontiers in …, 2023 - frontiersin.org
Aminoglycosides are used to treat infections caused by carbapenem-resistant Acinetobacter
baumannii (CRAB) strains. However, resistance to aminoglycosides has increased …

[HTML][HTML] Dissemination of carbapenemases producing Gram negative bacteria in the Middle East

HE Leylabadlo, M Asgharzadeh… - Iranian journal of …, 2015 - ncbi.nlm.nih.gov
The emergence and spread of carbapenemase-producing bacteria, that hydolyze most β-
lactams, including carbapenems, are a major concern of public health system worldwide …

[HTML][HTML] Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii

S El-Shazly, A Dashti, L Vali, M Bolaris… - International Journal of …, 2015 - Elsevier
Objectives The aim of this study was to identify the genetic relatedness of multiple drug-
resistant (MDR) Acinetobacter baumannii clinical isolates recovered from a hospital in Los …

[HTML][HTML] Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean …

A Sleiman, AG Abou Fayad, H Banna… - Journal of Global …, 2021 - Elsevier
Abstract Carbapenem resistance in Enterobacteriaceae, Acinetobacter baumannii, and
Pseudomonas aeruginosa is increasing worldwide, which led the WHO to list these bacteria …

Emerging status of multidrug-resistant bacteria and fungi in the arabian peninsula

JF Borgio, AS Rasdan, B Sonbol, G Alhamid… - Biology, 2021 - mdpi.com
Simple Summary The incidence and developing status of multidrug-resistant bacteria and
fungi, as well as their related mortality, is reviewed by a systematic published literature …